Hematopoietic Stem Cell Microtransplantation for in AML
Status:
Unknown status
Trial end date:
2018-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of hematopoietic stem cell
microtransplantation for in acute myeloid leukemia (AML)patients who can not receive
hematopoietic stem cell transplantation (HSCT).
Phase:
N/A
Details
Lead Sponsor:
Nanfang Hospital of Southern Medical University
Collaborators:
Guangzhou First People's Hospital Peking University People's Hospital Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Third Affiliated Hospital, Sun Yat-Sen University Zhujiang Hospital